Drug Profile
TAK 441
Alternative Names: TAK-441Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Millennium
- Class Antineoplastics; Pyridones; Pyrroles
- Mechanism of Action Hedgehog cell-signalling pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 04 Feb 2013 Discontinued - Phase-I for Solid tumours in USA (PO)
- 16 Sep 2010 Preclinical trials in Solid tumours in USA (PO)